Hypertension as a risk factor for diabetic neuropathy: a prospective study - PubMed (original) (raw)
Hypertension as a risk factor for diabetic neuropathy: a prospective study
K Y Forrest et al. Diabetes. 1997 Apr.
Abstract
The pathogeneses of diabetic neuropathy is still unclear. This study prospectively investigated the risk factors for distal symmetrical polyneuropathy (DSP) in a cohort of childhood-onset IDDM patients. Subjects from the Epidemiology of Diabetes Complications (EDC) Study were clinically examined at baseline and then biennially. DSP was diagnosed by a combination of clinical criteria, symptoms and signs (Diabetes Control and Complications Trial [DCCT] exam), and quantitative sensory threshold (QST). Among the 463 (70.4%) subjects who were free of DSP at baseline, 453 (97.8%) participated in at least one biennial reexamination during the first 6 years of follow-up and were included in the current analysis. A total of 68 (15.0%) subjects developed DSP in 6 years, giving a cumulative probability of 0.29. The Cox proportional hazards model shows that longer IDDM duration, hypertension, poor glycemic control, height, and smoking were all independent predictors of the incidence of DSP (all P < 0.0001, except for smoking for which P = 0.03). Hypertension showed the greatest impact on the development of DSP for individuals with either short or long IDDM duration. This study confirms some risk factors for DSP found in cross-sectional studies and suggests a strong relationship between hypertension and DSP. The results indicate that in addition to good glycemic control, avoidance of smoking and good blood pressure control may be helpful in preventing or delaying the onset of DSP in IDDM patients.
Similar articles
- Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study.
Orchard TJ, LLoyd CE, Maser RE, Kuller LH. Orchard TJ, et al. Diabetes Res Clin Pract. 1996 Oct;34 Suppl:S165-71. doi: 10.1016/s0168-8227(96)90025-x. Diabetes Res Clin Pract. 1996. PMID: 9015687 - Risk factors for progression of distal symmetric polyneuropathy in type 1 diabetes mellitus. Sorbinil Retinopathy Trial Research Group.
Christen WG, Manson JE, Bubes V, Glynn RJ. Christen WG, et al. Am J Epidemiol. 1999 Dec 1;150(11):1142-51. doi: 10.1093/oxfordjournals.aje.a009941. Am J Epidemiol. 1999. PMID: 10588075 - Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis.
Lloyd CE, Becker D, Ellis D, Orchard TJ. Lloyd CE, et al. Am J Epidemiol. 1996 Mar 1;143(5):431-41. doi: 10.1093/oxfordjournals.aje.a008763. Am J Epidemiol. 1996. PMID: 8610658 - Neuropathy in the DCCT/EDIC-What Was Done Then and What We Would Do Better Now.
Pop-Busui R, Martin C. Pop-Busui R, et al. Int Rev Neurobiol. 2016;127:9-25. doi: 10.1016/bs.irn.2016.02.020. Epub 2016 Apr 8. Int Rev Neurobiol. 2016. PMID: 27133142 Review. - Hypertension the 'Missed Modifiable Risk Factor' for Diabetic Neuropathy: a Systematic Review.
Sethi Y, Uniyal N, Vora V, Agarwal P, Murli H, Joshi A, Patel N, Chopra H, Hasabo EA, Kaka N. Sethi Y, et al. Curr Probl Cardiol. 2023 Apr;48(4):101581. doi: 10.1016/j.cpcardiol.2022.101581. Epub 2022 Dec 28. Curr Probl Cardiol. 2023. PMID: 36584725 Review.
Cited by
- Clinical and preclinical evidence that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy.
Iwane S, Nemoto W, Miyamoto T, Hayashi T, Tanaka M, Uchitani K, Muranaka T, Fujitani M, Koizumi Y, Hirata A, Tsubota M, Sekiguchi F, Tan-No K, Kawabata A. Iwane S, et al. Sci Rep. 2024 Jan 10;14(1):1039. doi: 10.1038/s41598-024-51572-z. Sci Rep. 2024. PMID: 38200077 Free PMC article. - How does diabetic peripheral neuropathy impact patients' burden of illness and the economy? A retrospective study in Beijing, China.
Pan Q, Fei S, Zhang L, Chen H, Luo J, Wang W, Xiao F, Guo L. Pan Q, et al. Front Public Health. 2023 May 12;11:1164536. doi: 10.3389/fpubh.2023.1164536. eCollection 2023. Front Public Health. 2023. PMID: 37250086 Free PMC article. - Predicting glycemic control status and high blood glucose levels through voice characteristic analysis in patients with cystic fibrosis-related diabetes (CFRD).
Suppakitjanusant P, Kasemkosin N, Sivapiromrat AK, Weinstein S, Ongphiphadhanakul B, Hunt WR, Sueblinvong V, Tangpricha V. Suppakitjanusant P, et al. Sci Rep. 2023 May 27;13(1):8617. doi: 10.1038/s41598-023-35416-w. Sci Rep. 2023. PMID: 37244957 Free PMC article. - The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy.
Kostourou DT, Milonas D, Polychronopoulos G, Sofogianni A, Tziomalos K. Kostourou DT, et al. J Pers Med. 2022 Jul 30;12(8):1253. doi: 10.3390/jpm12081253. J Pers Med. 2022. PMID: 36013202 Free PMC article. Review. - Determinants of Diabetic Peripheral Neuropathy and Their Clinical Significance: A Retrospective Cohort Study.
Cheng Y, Cao W, Zhang J, Wang J, Liu X, Wu Q, Lin Q. Cheng Y, et al. Front Endocrinol (Lausanne). 2022 Jul 26;13:934020. doi: 10.3389/fendo.2022.934020. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35957831 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous